Femasys (FEMY) Non-Current Assets (2020 - 2026)
Femasys' (FEMY) quarterly Non-Current Assets came in at $2.2 million in Q1 2026, down 13.32% YoY from $2.6 million in Q1 2025, and down 6.09% on a QoQ basis from $2.4 million in Q4 2025.
Femasys (FEMY) Non-Current Assets (2020 - 2026) Analysis & Trends
Femasys (FEMY) has 7 years of Non-Current Assets data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Non-Current Assets fell 13.32% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (down 13.32% YoY) and the FY2025 annual result came in at $2.4 million, down 16.07% from the prior year.
- Non-Current Assets slipped to $2.2 million in Q1 2026, from $2.4 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $3.5 million in Q3 2023 to a low of $1.0 million in Q2 2023.
- A 5-year average of $2.2 million and a median of $2.4 million in 2025 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2024 — Non-Current Assets surged 199.68% — and 2025, when it dropped 21.49%.
- Tracing FEMY's Non-Current Assets over 5 years: stood at $1.3 million in 2022, then soared by 170.63% to $3.5 million in 2023, then slipped by 18.47% to $2.8 million in 2024, then fell by 16.07% to $2.4 million in 2025, then slipped by 6.09% to $2.2 million in 2026.
- The last three Non-Current Assets figures came in at $2.2 million (Q1 2026), $2.4 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 11.33 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 42.59 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 24.47 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 4.64 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 27.61 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 2.27 Bn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 10.50 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 10.18 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 12.80 Bn |
| 10 | Femasys | 8.98 Mn | 7.54 Mn | 189,391.00 | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.23 Mn |
| Dec 31, 2025 | 2.37 Mn |
| Sep 30, 2025 | 2.29 Mn |
| Jun 30, 2025 | 2.43 Mn |
| Mar 31, 2025 | 2.57 Mn |
| Dec 31, 2024 | 2.83 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 3.08 Mn |
| Mar 31, 2024 | 3.27 Mn |
| Dec 31, 2023 | 3.47 Mn |
| Sep 30, 2023 | 3.47 Mn |
| Jun 30, 2023 | 1.03 Mn |
| Mar 31, 2023 | 1.16 Mn |
| Dec 31, 2022 | 1.28 Mn |
| Sep 30, 2022 | 1.20 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 1.22 Mn |
| Dec 31, 2021 | 1.35 Mn |
| Sep 30, 2021 | 1.22 Mn |
| Jun 30, 2021 | 1.39 Mn |